VENTURE Study Exploratory Analysis Shows VK2735 Improved Cardiometabolic Parameters After 13 Weeks; Reducing Prediabetes and Metabolic Syndrome SAN DIEGO, Nov. 6, 2025 /PRNewswire/ -- Viking ...

Now, in a presentation discussing the subject of remakes and remasters further, Ampere Analysis senior analyst Katie Holt has ...

Trial met primary endpoint, with statistically significant reductions in liver fat observed in all HU6 treatment groups –– In addition to ...

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

Companies are struggling to find and retain data analytics talent. Find out why there's a shortage of data analysts and what your business can do.

Newly released CREModels Lighthouse delivers asset-performance insights to investors and asset-managers in multifamily residential, office, retail, industrial and other sectors. ST. PETERSBURG, Fla., ...

This acceptance marks the fifth major medical conference this year to feature bexmarilimab in an oral session, reinforcing the drug's unique mechanism in hematologic malignancies and potential to ...

The Sangamon County Board’s timeline for considering and potentially approving the county’s first data center – a $500 ...

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that new data on ...

We made several strategic additions during market weakness including Fast Retailing, Chipotle, Gartner and Adyen. Read more here.

A presentation at AONN+ Annual Conference draws a connection between navigation and improved clinical trial accrual and NGS testing adherence.

Greenhaven Road Capital's Q3 2025 letter analyzes a -9% return, citing no AI exposure and undervalued software holdings.